17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
n this episode I visit with Sean Freidlin, the Senior Product Marketing Manager, Compliance at Hanzo...
Read More >
Dividend Timetable Revisions - On 25 March 2020, the LSE published Market Notice N07/20 which provi...
Read More >
Labor & Employment- Wendy’s: All the Goodness, But Hold the Alleged Child Labor Violations- Massa...
Read More >
Based on a recent Delaware Chancery Court decision, parties outside of a transaction—not just the b...
Read More >
In Wickersham Construction and Engineering, Inc. v. The Town of Sudlersville, Maryland (Sept. 22, 20...
Read More >
In response to the disruption in the market as a result of COVID-19, the Federal Trade Commission (F...
Read More >